NZ211659A - Cephalosporin derivatives; intermediates and pharmaceutical compositions - Google Patents

Cephalosporin derivatives; intermediates and pharmaceutical compositions

Info

Publication number
NZ211659A
NZ211659A NZ211659A NZ21165985A NZ211659A NZ 211659 A NZ211659 A NZ 211659A NZ 211659 A NZ211659 A NZ 211659A NZ 21165985 A NZ21165985 A NZ 21165985A NZ 211659 A NZ211659 A NZ 211659A
Authority
NZ
New Zealand
Prior art keywords
intermediates
pharmaceutical compositions
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
NZ211659A
Other languages
English (en)
Inventor
Yamashita Haruhiro
Oka Masahisa
Naito Takayuki
Okumura Jun
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ211659A publication Critical patent/NZ211659A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ211659A 1984-04-09 1985-04-02 Cephalosporin derivatives; intermediates and pharmaceutical compositions NZ211659A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09

Publications (1)

Publication Number Publication Date
NZ211659A true NZ211659A (en) 1988-11-29

Family

ID=24393575

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ211659A NZ211659A (en) 1984-04-09 1985-04-02 Cephalosporin derivatives; intermediates and pharmaceutical compositions

Country Status (31)

Country Link
JP (4) JPS615084A (sv)
KR (1) KR870002166B1 (sv)
AR (1) AR244694A1 (sv)
AT (1) AT388735B (sv)
AU (2) AU580990B2 (sv)
BE (1) BE902148A (sv)
CA (3) CA1276929C (sv)
CH (1) CH669197A5 (sv)
DD (3) DD249024A5 (sv)
DE (1) DE3512225A1 (sv)
DK (1) DK155985A (sv)
ES (4) ES8607318A1 (sv)
FI (1) FI84830C (sv)
FR (1) FR2563832B1 (sv)
GB (3) GB2157293B (sv)
GR (1) GR850883B (sv)
HU (2) HU193750B (sv)
IE (2) IE58408B1 (sv)
IL (1) IL74826A (sv)
IT (1) IT1190353B (sv)
LU (1) LU85840A1 (sv)
MY (1) MY101940A (sv)
NL (1) NL192925C (sv)
NZ (1) NZ211659A (sv)
OA (1) OA07985A (sv)
PT (1) PT80246B (sv)
RU (1) RU2056425C1 (sv)
SE (4) SE466205B (sv)
SU (4) SU1375140A3 (sv)
YU (2) YU46151B (sv)
ZA (1) ZA852236B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (ja) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd 新規セフエム化合物及びその製造法
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
DE3650157T2 (de) * 1985-12-26 1995-05-04 Eisai Co Ltd Cephalosporin-verbindungen.
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
JPH085897B2 (ja) * 1986-11-06 1996-01-24 エーザイ株式会社 ３−プロペニルセフェム誘導体
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
JPH0699449B2 (ja) * 1988-03-16 1994-12-07 エーザイ株式会社 セフェム誘導体の合成中間体
EP0612751A3 (en) * 1988-03-16 1994-09-21 Eisai Co Ltd Compounds for the preparation of cephem derivatives.
FR2655042B1 (fr) * 1989-11-29 1994-01-21 Adir Cie Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH0741484A (ja) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk セフェム化合物及び抗菌剤
US5661144A (en) * 1994-08-16 1997-08-26 Meiji Seika Kabushiki Kaisha Cephem derivatives with 3-substituted bis heterocycles
PL345266A1 (en) 1998-06-22 2001-12-03 Hoffmann La Roche Propenyl cephalosporin derivatives
EP1666483B1 (en) 2003-09-09 2011-08-17 Nippon Chemical Industrial Company Limited Process for producing 3-chloromethyl-3-cephem derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (de) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathiaverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (sv) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (sv) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
SE470260B (sv) 1993-12-20
FI84830C (sv) 1992-01-27
GB8721347D0 (en) 1987-10-14
SE8901225D0 (sv) 1989-04-06
BE902148A (fr) 1985-10-09
IE58403B1 (en) 1993-09-22
ZA852236B (en) 1985-11-27
IT1190353B (it) 1988-02-16
DE3512225A1 (de) 1985-10-17
NL192925B (nl) 1998-01-05
YU118987A (en) 1988-10-31
PT80246A (en) 1985-05-01
SE8501680D0 (sv) 1985-04-03
YU46213B (sh) 1993-05-28
NL192925C (nl) 1998-05-07
DD249024A5 (de) 1987-08-26
RU2056425C1 (ru) 1996-03-20
JPH0350754B2 (sv) 1991-08-02
HU193750B (en) 1987-11-30
ES542013A0 (es) 1986-06-16
DD251752A5 (de) 1987-11-25
ES8800949A1 (es) 1987-12-01
KR870002166B1 (ko) 1987-12-14
SE8901224D0 (sv) 1989-04-06
SE8901226L (sv) 1989-04-06
SE8501680L (sv) 1985-10-10
LU85840A1 (fr) 1985-12-16
ES551550A0 (es) 1987-06-01
GB2194789B (en) 1988-10-12
KR850007424A (ko) 1985-12-04
JPH0351716B2 (sv) 1991-08-07
FI84830B (fi) 1991-10-15
AU580990B2 (en) 1989-02-09
DD236735A5 (de) 1986-06-18
GB2157293B (en) 1988-10-05
SE470259B (sv) 1993-12-20
JPH0262557B2 (sv) 1990-12-26
AR244694A1 (es) 1993-11-30
IE58408B1 (en) 1993-09-22
OA07985A (fr) 1987-01-31
ES557060A0 (es) 1987-12-01
GR850883B (sv) 1985-11-25
ES8607318A1 (es) 1986-06-16
NL8501002A (nl) 1985-11-01
FR2563832B1 (fr) 1989-08-18
MY101940A (en) 1992-02-15
GB8721346D0 (en) 1987-10-14
PT80246B (pt) 1987-10-20
JPS615084A (ja) 1986-01-10
SU1436882A3 (ru) 1988-11-07
GB8508846D0 (en) 1985-05-09
IE850866L (en) 1985-10-09
ES551551A0 (es) 1987-07-01
FI851379L (fi) 1985-10-10
GB2194790A (en) 1988-03-16
SE505256C2 (sv) 1997-07-21
GB2194790B (en) 1988-10-05
YU46151B (sh) 1993-05-28
IT8520267A0 (it) 1985-04-05
HU204277B (en) 1991-12-30
AU610278B2 (en) 1991-05-16
IL74826A0 (en) 1985-07-31
CH669197A5 (de) 1989-02-28
IL74826A (en) 1990-01-18
SU1367858A3 (ru) 1988-01-15
AU2504188A (en) 1989-03-02
GB2194789A (en) 1988-03-16
GB2157293A (en) 1985-10-23
SE8901225L (sv) 1989-04-06
SE466205B (sv) 1992-01-13
SE8901226D0 (sv) 1989-04-06
FI851379A0 (fi) 1985-04-04
JPH0357106B2 (sv) 1991-08-30
FR2563832A1 (fr) 1985-11-08
AT388735B (de) 1989-08-25
JPS61143390A (ja) 1986-07-01
CA1276929C (en) 1990-11-27
HUT37622A (en) 1986-01-23
CA1340638C (en) 1999-07-06
SU1375140A3 (ru) 1988-02-15
SE8901224L (sv) 1989-04-06
YU60085A (en) 1987-12-31
JPS61143387A (ja) 1986-07-01
DE3512225C2 (sv) 1990-02-22
ATA103985A (de) 1989-01-15
ES8706694A1 (es) 1987-07-01
CA1340672C (en) 1999-07-20
JPS61143391A (ja) 1986-07-01
SU1487814A3 (ru) 1989-06-15
AU4086285A (en) 1985-10-17
DK155985A (da) 1985-10-10
ES8706155A1 (es) 1987-06-01
DK155985D0 (da) 1985-04-03

Similar Documents

Publication Publication Date Title
NZ212415A (en) 2-benzimidazolyl 2-pyridylmethylsulphide derivatives and pharmaceutical compositions
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ216678A (en) Heterocyclic substituted-phenoxyalkyl-isoxazoles and -furans and pharmaceutical compositions
NZ224129A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ212521A (en) Sulphonylurea derivatives and pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
NZ211659A (en) Cephalosporin derivatives; intermediates and pharmaceutical compositions
NZ212499A (en) Substituted benzamide derivatives and pharmaceutical compositions
NZ215333A (en) Cephem compounds and pharmaceutical compositions
NZ201833A (en) Thieno-and furopyridinium-substituted cephalosporin derivatives and pharmaceutical compositions
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ221052A (en) Cephalosporin derivatives, pharmaceutical compositions and intermediates
NZ212320A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ213798A (en) Guanine derivatives and pharmaceutical compositions
NZ211594A (en) The preparation of certain cephalosporin derivatives
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ216894A (en) Penicillin derivatives and pharmaceutical compositions
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
NZ213877A (en) Peptide-substituted heterocyclic derivatives and pharmaceutical compositions
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
NZ224130A (en) Cephalosporin derivatives and pharmaceutical compositions